关注
Bridin Murnion
Bridin Murnion
在 sydney.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies
E Stockings, G Campbell, WD Hall, S Nielsen, D Zagic, R Rahman, ...
Pain 159 (10), 1932-1954, 2018
4522018
Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis
S Nielsen, P Sabioni, JM Trigo, MA Ware, BD Betz-Stablein, B Murnion, ...
Neuropsychopharmacology 42 (9), 1752-1765, 2017
2812017
Management of benzodiazepine misuse and dependence
J Brett, B Murnion
Australian prescriber 38 (5), 152, 2015
2812015
The assessment of frailty in older people in acute care
SN Hilmer, V Perera, S Mitchell, BP Murnion, J Dent, B Bajorek, ...
Australasian journal on ageing 28 (4), 182-188, 2009
2622009
Neuropathic pain: current definition and review of drug treatment
BP Murnion
Australian prescriber 41 (3), 60, 2018
1832018
Examination of opioid prescribing in Australia from 1992 to 2007
M Leong, B Murnion, PS Haber
Internal medicine journal 39 (10), 676-681, 2009
1672009
Management of injecting drug users admitted to hospital
PS Haber, A Demirkol, K Lange, B Murnion
The Lancet 374 (9697), 1284-1293, 2009
1532009
Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial
CMP Jones, RO Day, BW Koes, J Latimer, CG Maher, AJ McLachlan, ...
The Lancet 402 (10398), 304-312, 2023
842023
Prescription and administration of opioids to hospital in-patients, and barriers to effective use
BP Murnion, D Gnjidic, SN Hilmer
Pain Medicine 11 (1), 58-66, 2010
802010
Medicinal cannabis
B Murnion
Australian prescriber 38 (6), 2015
672015
Hepatotoxicity of therapeutic short‐course paracetamol in hospital inpatients: impact of ageing and frailty
SJ Mitchell, SN Hilmer, BP Murnion, S Matthews
Journal of Clinical Pharmacy and Therapeutics 36 (3), 327-335, 2011
612011
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
S Nielsen, L Picco, B Murnion, B Winters, J Matheson, M Graham, ...
Neuropsychopharmacology 47 (7), 1315-1330, 2022
542022
Perceived stigma and social support in treatment for pharmaceutical opioid dependence
S Cooper, G Campbell, B Larance, B Murnion, S Nielsen
Drug and alcohol review 37 (2), 262-272, 2018
542018
Excitation and inhibition of rat medial vestibular nucleus neurones by 5-hydroxytryptamine
AR Johnston, B Murnion, DS McQueen, MB Dutia
Experimental brain research 93, 293-298, 1993
541993
General practitioners' diagnostic skills and referral practices in managing patients with drug and alcohol‐related health problems: implications for medical training and …
USAM FUCITO, BS Gomes, B Murnion, PS Haber
Drug and alcohol review 22 (4), 417-424, 2003
482003
Cannabinoids for the treatment of spasticity
S Nielsen, B Murnion, G Campbell, H Young, W Hall
Developmental Medicine & Child Neurology 61 (6), 631-638, 2019
422019
Combination analgesics in adults
BP Murnion
Aust Prescr 33 (4), 113-5, 2010
392010
Comparing treatment‐seeking codeine users and strong opioid users: findings from a novel case series
S Nielsen, B Murnion, A Dunlop, L Degenhardt, A Demirkol, P Muhleisen, ...
Drug and Alcohol Review 34 (3), 304-311, 2015
372015
Current insights on the impact of gamma-hydroxybutyrate (GHB) abuse
E Tay, WKW Lo, B Murnion
Substance Abuse and Rehabilitation, 13-23, 2022
282022
Routine opioid outcome monitoring in community pharmacy: pilot implementation study protocol
S Nielsen, M Kowalski, P Wood, S Larney, R Bruno, M Shanahan, ...
Research in Social and Administrative Pharmacy 15 (8), 1047-1055, 2019
252019
系统目前无法执行此操作,请稍后再试。
文章 1–20